Zacks Research Has Optimistic Outlook of Integer Q1 Earnings

Integer Holdings Co. (NYSE:ITGR - Free Report) - Analysts at Zacks Research increased their Q1 2026 earnings estimates for Integer in a research note issued on Thursday, May 15th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will post earnings per share of $1.61 for the quarter, up from their prior forecast of $1.59. The consensus estimate for Integer's current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer's Q2 2026 earnings at $1.62 EPS.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 earnings per share.

Several other research firms have also recently weighed in on ITGR. Benchmark cut their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Raymond James increased their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Finally, Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and increased their target price for the stock from $133.00 to $140.00 in a report on Thursday. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $145.00.

Integer Price Performance

ITGR traded up $0.27 on Monday, hitting $118.43. 244,616 shares of the stock were exchanged, compared to its average volume of 372,916. Integer has a 12 month low of $104.93 and a 12 month high of $146.36. The business has a 50-day moving average of $118.40 and a two-hundred day moving average of $129.17. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market capitalization of $4.13 billion, a price-to-earnings ratio of 35.25, a PEG ratio of 1.72 and a beta of 1.03.

Insiders Place Their Bets

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.16% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ITGR. Mather Group LLC. increased its stake in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 143 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of Integer during the fourth quarter valued at about $27,000. AdvisorNet Financial Inc bought a new position in shares of Integer during the 1st quarter worth about $28,000. Opal Wealth Advisors LLC acquired a new stake in shares of Integer in the 1st quarter valued at about $28,000. Finally, Bessemer Group Inc. raised its stake in Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after buying an additional 125 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.